Global Insomnia Therapeutics Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Mar, 2020
|
Report ID: 120431
|
101
|
Pharmaceuticals and Healthcare
Market Overview
The global Insomnia Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insomnia Therapeutics Drugs
market has been segmented into:
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
By Application, Insomnia Therapeutics Drugs has been segmented into:
Prescription
Over-the-Counter (OTC)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insomnia Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Insomnia Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insomnia Therapeutics Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Insomnia Therapeutics Drugs market in
important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Insomnia Therapeutics Drugs Market Share Analysis
Insomnia Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insomnia Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insomnia Therapeutics Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Insomnia Therapeutics Drugs are:
Takeda Pharmaceutical Company Ltd.
Sanofi
Pfizer Inc.
Vanda Pharmaceuticals
Sumitomo Dainippon Pharma Co., Ltd
Merck & Co., Inc.
Ebb Therapeutics
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Paratek Pharmaceuticals Inc.
The global Insomnia Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insomnia Therapeutics Drugs
market has been segmented into:
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
By Application, Insomnia Therapeutics Drugs has been segmented into:
Prescription
Over-the-Counter (OTC)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insomnia Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Insomnia Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insomnia Therapeutics Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Insomnia Therapeutics Drugs market in
important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Insomnia Therapeutics Drugs Market Share Analysis
Insomnia Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insomnia Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insomnia Therapeutics Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Insomnia Therapeutics Drugs are:
Takeda Pharmaceutical Company Ltd.
Sanofi
Pfizer Inc.
Vanda Pharmaceuticals
Sumitomo Dainippon Pharma Co., Ltd
Merck & Co., Inc.
Ebb Therapeutics
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Paratek Pharmaceuticals Inc.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Insomnia Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Insomnia Therapeutics Drugs
1.2 Classification of Insomnia Therapeutics Drugs by Type
1.2.1 Global Insomnia Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2019
1.2.3 Benzodiazepines
1.2.4 Nonbenzodiazepines
1.2.5 Antidepressants
1.2.6 Orexin Antagonists
1.2.7 Melatonin Antagonists
1.2.8 Others
1.3 Global Insomnia Therapeutics Drugs Market by Application
1.3.1 Overview: Global Insomnia Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Global Insomnia Therapeutics Drugs Market by Regions
1.4.1 Global Insomnia Therapeutics Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Insomnia Therapeutics Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda Pharmaceutical Company Ltd.
2.1.1 Takeda Pharmaceutical Company Ltd. Details
2.1.2 Takeda Pharmaceutical Company Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceutical Company Ltd. SWOT Analysis
2.1.4 Takeda Pharmaceutical Company Ltd. Product and Services
2.1.5 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer Inc. SWOT Analysis
2.3.4 Pfizer Inc. Product and Services
2.3.5 Pfizer Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vanda Pharmaceuticals
2.4.1 Vanda Pharmaceuticals Details
2.4.2 Vanda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Vanda Pharmaceuticals SWOT Analysis
2.4.4 Vanda Pharmaceuticals Product and Services
2.4.5 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sumitomo Dainippon Pharma Co., Ltd
2.5.1 Sumitomo Dainippon Pharma Co., Ltd Details
2.5.2 Sumitomo Dainippon Pharma Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sumitomo Dainippon Pharma Co., Ltd SWOT Analysis
2.5.4 Sumitomo Dainippon Pharma Co., Ltd Product and Services
2.5.5 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co., Inc. SWOT Analysis
2.6.4 Merck & Co., Inc. Product and Services
2.6.5 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ebb Therapeutics
2.7.1 Ebb Therapeutics Details
2.7.2 Ebb Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ebb Therapeutics SWOT Analysis
2.7.4 Ebb Therapeutics Product and Services
2.7.5 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan N.V.
2.8.1 Mylan N.V. Details
2.8.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan N.V. SWOT Analysis
2.8.4 Mylan N.V. Product and Services
2.8.5 Mylan N.V. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.9.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.9.5 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Paratek Pharmaceuticals Inc.
2.10.1 Paratek Pharmaceuticals Inc. Details
2.10.2 Paratek Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Paratek Pharmaceuticals Inc. SWOT Analysis
2.10.4 Paratek Pharmaceuticals Inc. Product and Services
2.10.5 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Insomnia Therapeutics Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Insomnia Therapeutics Drugs Players Market Share
3.2.2 Top 10 Insomnia Therapeutics Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Regions
4.2 North America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5 North America Insomnia Therapeutics Drugs Revenue by Countries
5.1 North America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
5.2 USA Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6 Europe Insomnia Therapeutics Drugs Revenue by Countries
6.1 Europe Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
6.2 Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.4 France Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Countries
7.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
7.2 China Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.5 India Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8 South America Insomnia Therapeutics Drugs Revenue by Countries
8.1 South America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
8.2 Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Insomnia Therapeutics Drugs by Countries
9.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Insomnia Therapeutics Drugs Market Forecast by Type (2019-2024)
10.3 Benzodiazepines Revenue Growth Rate (2015-2025)
10.4 Nonbenzodiazepines Revenue Growth Rate (2015-2025)
10.5 Antidepressants Revenue Growth Rate (2015-2025)
10.6 Orexin Antagonists Revenue Growth Rate (2015-2025)
10.7 Melatonin Antagonists Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Insomnia Therapeutics Drugs Market Segment by Application
11.1 Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.2 Insomnia Therapeutics Drugs Market Forecast by Application (2019-2024)
11.3 Prescription Revenue Growth (2015-2020)
11.4 Over-the-Counter (OTC) Revenue Growth (2015-2020)
12 Global Insomnia Therapeutics Drugs Market Size Forecast (2021-2025)
12.1 Global Insomnia Therapeutics Drugs Market Size Forecast (2021-2025)
12.2 Global Insomnia Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.3 North America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.6 South America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
1 Insomnia Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Insomnia Therapeutics Drugs
1.2 Classification of Insomnia Therapeutics Drugs by Type
1.2.1 Global Insomnia Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2019
1.2.3 Benzodiazepines
1.2.4 Nonbenzodiazepines
1.2.5 Antidepressants
1.2.6 Orexin Antagonists
1.2.7 Melatonin Antagonists
1.2.8 Others
1.3 Global Insomnia Therapeutics Drugs Market by Application
1.3.1 Overview: Global Insomnia Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Global Insomnia Therapeutics Drugs Market by Regions
1.4.1 Global Insomnia Therapeutics Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Insomnia Therapeutics Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Insomnia Therapeutics Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda Pharmaceutical Company Ltd.
2.1.1 Takeda Pharmaceutical Company Ltd. Details
2.1.2 Takeda Pharmaceutical Company Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceutical Company Ltd. SWOT Analysis
2.1.4 Takeda Pharmaceutical Company Ltd. Product and Services
2.1.5 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer Inc. SWOT Analysis
2.3.4 Pfizer Inc. Product and Services
2.3.5 Pfizer Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vanda Pharmaceuticals
2.4.1 Vanda Pharmaceuticals Details
2.4.2 Vanda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Vanda Pharmaceuticals SWOT Analysis
2.4.4 Vanda Pharmaceuticals Product and Services
2.4.5 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sumitomo Dainippon Pharma Co., Ltd
2.5.1 Sumitomo Dainippon Pharma Co., Ltd Details
2.5.2 Sumitomo Dainippon Pharma Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sumitomo Dainippon Pharma Co., Ltd SWOT Analysis
2.5.4 Sumitomo Dainippon Pharma Co., Ltd Product and Services
2.5.5 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co., Inc. SWOT Analysis
2.6.4 Merck & Co., Inc. Product and Services
2.6.5 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ebb Therapeutics
2.7.1 Ebb Therapeutics Details
2.7.2 Ebb Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ebb Therapeutics SWOT Analysis
2.7.4 Ebb Therapeutics Product and Services
2.7.5 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan N.V.
2.8.1 Mylan N.V. Details
2.8.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan N.V. SWOT Analysis
2.8.4 Mylan N.V. Product and Services
2.8.5 Mylan N.V. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.9.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.9.5 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Paratek Pharmaceuticals Inc.
2.10.1 Paratek Pharmaceuticals Inc. Details
2.10.2 Paratek Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Paratek Pharmaceuticals Inc. SWOT Analysis
2.10.4 Paratek Pharmaceuticals Inc. Product and Services
2.10.5 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Insomnia Therapeutics Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Insomnia Therapeutics Drugs Players Market Share
3.2.2 Top 10 Insomnia Therapeutics Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Regions
4.2 North America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5 North America Insomnia Therapeutics Drugs Revenue by Countries
5.1 North America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
5.2 USA Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6 Europe Insomnia Therapeutics Drugs Revenue by Countries
6.1 Europe Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
6.2 Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.4 France Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Countries
7.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
7.2 China Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.5 India Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8 South America Insomnia Therapeutics Drugs Revenue by Countries
8.1 South America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
8.2 Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Insomnia Therapeutics Drugs by Countries
9.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Insomnia Therapeutics Drugs Market Forecast by Type (2019-2024)
10.3 Benzodiazepines Revenue Growth Rate (2015-2025)
10.4 Nonbenzodiazepines Revenue Growth Rate (2015-2025)
10.5 Antidepressants Revenue Growth Rate (2015-2025)
10.6 Orexin Antagonists Revenue Growth Rate (2015-2025)
10.7 Melatonin Antagonists Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Insomnia Therapeutics Drugs Market Segment by Application
11.1 Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.2 Insomnia Therapeutics Drugs Market Forecast by Application (2019-2024)
11.3 Prescription Revenue Growth (2015-2020)
11.4 Over-the-Counter (OTC) Revenue Growth (2015-2020)
12 Global Insomnia Therapeutics Drugs Market Size Forecast (2021-2025)
12.1 Global Insomnia Therapeutics Drugs Market Size Forecast (2021-2025)
12.2 Global Insomnia Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.3 North America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.6 South America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Insomnia Therapeutics Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Pharmaceutical Company Ltd. Corporate Information, Location and Competitors
Table 6. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Major Business
Table 7. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Takeda Pharmaceutical Company Ltd. SWOT Analysis
Table 9. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 10. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Insomnia Therapeutics Drugs Major Business
Table 13. Sanofi Insomnia Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Insomnia Therapeutics Drugs Product and Solutions
Table 16. Sanofi Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Inc. Corporate Information, Location and Competitors
Table 18. Pfizer Inc. Insomnia Therapeutics Drugs Major Business
Table 19. Pfizer Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer Inc. SWOT Analysis
Table 21. Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 22. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Vanda Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Major Business
Table 25. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Vanda Pharmaceuticals SWOT Analysis
Table 27. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
Table 28. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sumitomo Dainippon Pharma Co., Ltd Corporate Information, Location and Competitors
Table 30. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Major Business
Table 31. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Sumitomo Dainippon Pharma Co., Ltd SWOT Analysis
Table 33. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
Table 34. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 36. Merck & Co., Inc. Insomnia Therapeutics Drugs Major Business
Table 37. Merck & Co., Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Merck & Co., Inc. SWOT Analysis
Table 39. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 40. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ebb Therapeutics Corporate Information, Location and Competitors
Table 42. Ebb Therapeutics Insomnia Therapeutics Drugs Major Business
Table 43. Ebb Therapeutics Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Ebb Therapeutics SWOT Analysis
Table 45. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
Table 46. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Mylan N.V. Corporate Information, Location and Competitors
Table 48. Mylan N.V. Insomnia Therapeutics Drugs Major Business
Table 49. Mylan N.V. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Mylan N.V. SWOT Analysis
Table 51. Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
Table 52. Mylan N.V. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 54. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Major Business
Table 55. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 57. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 58. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Paratek Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 60. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Major Business
Table 61. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Paratek Pharmaceuticals Inc. SWOT Analysis
Table 63. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 64. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Players (2015-2020)
Table 66. Global Insomnia Therapeutics Drugs Revenue Share by Players (2015-2020)
Table 67. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Table 69. North America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
Table 70. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Europe Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
Table 74. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Type (2015-2020)
Table 78. Global Insomnia Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 79. Global Insomnia Therapeutics Drugs Revenue Forecast by Type (2021-2025)
Table 80. Global Insomnia Therapeutics Drugs Revenue by Application (2015-2020)
Table 81. Global Insomnia Therapeutics Drugs Revenue Share by Application (2015-2020)
Table 82. Global Insomnia Therapeutics Drugs Revenue Forecast by Application (2021-2025)
Table 83. Global Insomnia Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 3. Benzodiazepines Picture
Figure 4. Nonbenzodiazepines Picture
Figure 5. Antidepressants Picture
Figure 6. Orexin Antagonists Picture
Figure 7. Melatonin Antagonists Picture
Figure 8. Others Picture
Figure 9. Insomnia Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 10. Prescription Picture
Figure 11. Over-the-Counter (OTC) Picture
Figure 12. Global Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Insomnia Therapeutics Drugs Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Insomnia Therapeutics Drugs Revenue Market Share in 2019
Figure 21. Global Top 10 Players Insomnia Therapeutics Drugs Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 25. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 26. North America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Europe Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 29. South America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 31. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 32. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 33. USA Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Europe Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 38. Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 39. UK Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 40. France Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 45. China Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 48. India Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 50. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 52. Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 57. UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Global Insomnia Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 61. Global Insomnia Therapeutics Drugs Revenue Share by Type in 2019
Figure 62. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Figure 63. Global Benzodiazepines Revenue Growth Rate (2015-2020)
Figure 64. Global Nonbenzodiazepines Revenue Growth Rate (2015-2020)
Figure 65. Global Antidepressants Revenue Growth Rate (2015-2020)
Figure 66. Global Orexin Antagonists Revenue Growth Rate (2015-2020)
Figure 67. Global Melatonin Antagonists Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Insomnia Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 70. Global Insomnia Therapeutics Drugs Revenue Share by Application in 2019
Figure 71. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Figure 72. Global Prescription Revenue Growth Rate (2015-2020)
Figure 73. Global Over-the-Counter (OTC) Revenue Growth Rate (2015-2020)
Figure 74. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Insomnia Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Insomnia Therapeutics Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 78. Europe Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 80. South America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Insomnia Therapeutics Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Pharmaceutical Company Ltd. Corporate Information, Location and Competitors
Table 6. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Major Business
Table 7. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Takeda Pharmaceutical Company Ltd. SWOT Analysis
Table 9. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 10. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Insomnia Therapeutics Drugs Major Business
Table 13. Sanofi Insomnia Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Insomnia Therapeutics Drugs Product and Solutions
Table 16. Sanofi Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Inc. Corporate Information, Location and Competitors
Table 18. Pfizer Inc. Insomnia Therapeutics Drugs Major Business
Table 19. Pfizer Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer Inc. SWOT Analysis
Table 21. Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 22. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Vanda Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Major Business
Table 25. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Vanda Pharmaceuticals SWOT Analysis
Table 27. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions
Table 28. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sumitomo Dainippon Pharma Co., Ltd Corporate Information, Location and Competitors
Table 30. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Major Business
Table 31. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Sumitomo Dainippon Pharma Co., Ltd SWOT Analysis
Table 33. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions
Table 34. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 36. Merck & Co., Inc. Insomnia Therapeutics Drugs Major Business
Table 37. Merck & Co., Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Merck & Co., Inc. SWOT Analysis
Table 39. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 40. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ebb Therapeutics Corporate Information, Location and Competitors
Table 42. Ebb Therapeutics Insomnia Therapeutics Drugs Major Business
Table 43. Ebb Therapeutics Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Ebb Therapeutics SWOT Analysis
Table 45. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions
Table 46. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Mylan N.V. Corporate Information, Location and Competitors
Table 48. Mylan N.V. Insomnia Therapeutics Drugs Major Business
Table 49. Mylan N.V. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Mylan N.V. SWOT Analysis
Table 51. Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions
Table 52. Mylan N.V. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 54. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Major Business
Table 55. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 57. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions
Table 58. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Paratek Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 60. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Major Business
Table 61. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Paratek Pharmaceuticals Inc. SWOT Analysis
Table 63. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions
Table 64. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Players (2015-2020)
Table 66. Global Insomnia Therapeutics Drugs Revenue Share by Players (2015-2020)
Table 67. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Table 69. North America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
Table 70. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Europe Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Insomnia Therapeutics Drugs Revenue by Countries (2015-2020)
Table 74. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Insomnia Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Global Insomnia Therapeutics Drugs Revenue (Million USD) by Type (2015-2020)
Table 78. Global Insomnia Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 79. Global Insomnia Therapeutics Drugs Revenue Forecast by Type (2021-2025)
Table 80. Global Insomnia Therapeutics Drugs Revenue by Application (2015-2020)
Table 81. Global Insomnia Therapeutics Drugs Revenue Share by Application (2015-2020)
Table 82. Global Insomnia Therapeutics Drugs Revenue Forecast by Application (2021-2025)
Table 83. Global Insomnia Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Insomnia Therapeutics Drugs Picture
Figure 2. Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 3. Benzodiazepines Picture
Figure 4. Nonbenzodiazepines Picture
Figure 5. Antidepressants Picture
Figure 6. Orexin Antagonists Picture
Figure 7. Melatonin Antagonists Picture
Figure 8. Others Picture
Figure 9. Insomnia Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 10. Prescription Picture
Figure 11. Over-the-Counter (OTC) Picture
Figure 12. Global Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Insomnia Therapeutics Drugs Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Insomnia Therapeutics Drugs Revenue Market Share in 2019
Figure 21. Global Top 10 Players Insomnia Therapeutics Drugs Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 25. Global Insomnia Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 26. North America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Europe Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 29. South America Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 31. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 32. North America Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 33. USA Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Europe Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 38. Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 39. UK Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 40. France Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 45. China Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 48. India Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 50. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. South America Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 52. Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 57. UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Insomnia Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Global Insomnia Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 61. Global Insomnia Therapeutics Drugs Revenue Share by Type in 2019
Figure 62. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Figure 63. Global Benzodiazepines Revenue Growth Rate (2015-2020)
Figure 64. Global Nonbenzodiazepines Revenue Growth Rate (2015-2020)
Figure 65. Global Antidepressants Revenue Growth Rate (2015-2020)
Figure 66. Global Orexin Antagonists Revenue Growth Rate (2015-2020)
Figure 67. Global Melatonin Antagonists Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Insomnia Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 70. Global Insomnia Therapeutics Drugs Revenue Share by Application in 2019
Figure 71. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Figure 72. Global Prescription Revenue Growth Rate (2015-2020)
Figure 73. Global Over-the-Counter (OTC) Revenue Growth Rate (2015-2020)
Figure 74. Global Insomnia Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Insomnia Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Insomnia Therapeutics Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 78. Europe Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 80. South America Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
